Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synergistic Effects of Albuterol and Caffeine on Metabolic Rate
NCT02135965Phase 1Completed
- Sponsor
- Pennington Biomedical Research Center
- Start
- Apr 2009
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of salbutamol and caffeine in obesity (8 arms), sponsored by Pennington Biomedical Research Center. Primary endpoint: Change in Metabolic Rate at 10 weeks. Started Apr 2009; status: completed.
02
Drugs
salbutamolcaffeine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02135965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02135965.